학술논문
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
Document Type
Article
Author
Source
In: Antibiotics . (Antibiotics, April 2024, 13(4))
Subject
Language
English
ISSN
20796382